Winters Chad
VP, Chief Accounting Officer
Winters Chad has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Apr 29, 2026.
On the most recent filing, Winters Chad is listed as VP, Chief Accounting Officer at WEST PHARMACEUTICAL SERVICES INC. Inside the rolling window, Winters Chad reported no open-market purchases and 1 open-market sale totaling $269K in WST.
Companies traded
Other insiders at WST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$269K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Winters Chad made?
Winters Chad has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Winters Chad trade?
Winters Chad has filed SEC Form 4 disclosures for 1 company, including WST.
When was Winters Chad's most recent SEC Form 4 filing?
Winters Chad's most recent SEC Form 4 filing on Tracefour is dated Apr 29, 2026.
What is Winters Chad's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Winters Chad is listed as VP, Chief Accounting Officer.
What is Winters Chad's total buy and sell value in the current window?
Inside the rolling retention window, Winters Chad bought $0 and sold $269K based on SEC Form 4 filings.
What was Winters Chad's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 896 WST shares on 2026-04-27, worth $269K, per SEC Form 4 filings.